JPS568320A - Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent - Google Patents

Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Info

Publication number
JPS568320A
JPS568320A JP8468179A JP8468179A JPS568320A JP S568320 A JPS568320 A JP S568320A JP 8468179 A JP8468179 A JP 8468179A JP 8468179 A JP8468179 A JP 8468179A JP S568320 A JPS568320 A JP S568320A
Authority
JP
Japan
Prior art keywords
lipopolysaccharide
mycobacterium tuberculosis
drug
strain
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8468179A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6256843B2 (enExample
Inventor
Chisato Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP8468179A priority Critical patent/JPS568320A/ja
Priority to US06/147,127 priority patent/US4329452A/en
Priority to FR8012794A priority patent/FR2484258A1/fr
Priority to ES493061A priority patent/ES493061A0/es
Priority to SU802943651A priority patent/SU1232124A3/ru
Priority to IT23219/80A priority patent/IT1132168B/it
Priority to CH5128/80A priority patent/CH650799A5/de
Priority to CA355,290A priority patent/CA1132047A/en
Publication of JPS568320A publication Critical patent/JPS568320A/ja
Priority to US06/293,999 priority patent/US4394502A/en
Publication of JPS6256843B2 publication Critical patent/JPS6256843B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP8468179A 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent Granted JPS568320A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
US06/147,127 US4329452A (en) 1979-07-04 1980-05-06 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component
FR8012794A FR2484258A1 (fr) 1979-07-04 1980-06-09 Agent immunotherapique pour tumeurs, avec du lipopolysaccharide comme composant actif, et procede de preparation de cet agent
IT23219/80A IT1132168B (it) 1979-07-04 1980-07-03 Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo
SU802943651A SU1232124A3 (ru) 1979-07-04 1980-07-03 Способ получени липоарабиноманнана,обладающего противоопухолевой активностью
ES493061A ES493061A0 (es) 1979-07-04 1980-07-03 Un procedimiento para preparar un lipopolisacarido
CH5128/80A CH650799A5 (de) 1979-07-04 1980-07-03 Verfahren zur herstellung von lipopolysacchariden mit antitumoraktivitaet und immunotherapeutische mittel gegen tumore.
CA355,290A CA1132047A (en) 1979-07-04 1980-07-03 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component
US06/293,999 US4394502A (en) 1979-07-04 1981-08-18 Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Publications (2)

Publication Number Publication Date
JPS568320A true JPS568320A (en) 1981-01-28
JPS6256843B2 JPS6256843B2 (enExample) 1987-11-27

Family

ID=13837428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8468179A Granted JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Country Status (8)

Country Link
US (2) US4329452A (enExample)
JP (1) JPS568320A (enExample)
CA (1) CA1132047A (enExample)
CH (1) CH650799A5 (enExample)
ES (1) ES493061A0 (enExample)
FR (1) FR2484258A1 (enExample)
IT (1) IT1132168B (enExample)
SU (1) SU1232124A3 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718619A (en) * 1980-07-10 1982-01-30 Chisato Maruyama Tumor immunotherapy agent containing lipopolysaccharide as active principle
WO2013180114A1 (ja) * 2012-05-28 2013-12-05 エヌエーアイ株式会社 認知症の治療剤及び予防剤
WO2022075458A1 (ja) * 2020-10-09 2022-04-14 ゼリア新薬工業株式会社 結核菌抽出物の新規用途

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59161320A (ja) * 1983-03-04 1984-09-12 Maruyama Chisato リポ多糖体およびその製造法
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
EP0295749A1 (en) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
US4798369A (en) * 1987-11-03 1989-01-17 The Firestone Tire & Rubber Company Ultrasonic air spring system
US5853737A (en) * 1992-12-10 1998-12-29 Brigham And Women's Hospital Method for inducing a CD1-restricted immune response
US6238676B1 (en) * 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5712123A (en) * 1994-10-07 1998-01-27 Board Of Trustees Of The University Of Illinois Mixture having antitumor activities
WO1998056941A1 (en) * 1995-12-12 1998-12-17 Tai Ho Chung Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
US5869645A (en) * 1997-10-15 1999-02-09 Board Of Trustees Of The University Of Illinois Method for isolating high molecular weight antineoplastic glycans using urea
NZ505538A (en) * 2000-07-03 2004-12-24 Malaghan Inst Of Medical Res A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
PL1765391T3 (pl) * 2004-06-07 2013-08-30 Qu Biologics Inc Kompozycje bakteryjne do leczenia nowotworów
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20070161546A1 (en) * 2005-12-15 2007-07-12 Colm King Methods and compositions for treatment of cancer
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
EP3125763A4 (en) 2014-03-31 2017-12-13 University of Utah Research Foundation Fluid analysis device and associated systems and methods
CA3254723A1 (en) 2014-05-02 2025-04-15 Qu Biologics Inc ANTIMICROBIAL IMMUNOMODULATION

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2227862A1 (en) * 1973-05-04 1974-11-29 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
JPS5132794A (en) * 1974-06-20 1976-03-19 Anvar Koshuyokoirusu oyobi ajubantokatsuseiojusuru maikobakuteriumufurakushonnoseiseiho

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718619A (en) * 1980-07-10 1982-01-30 Chisato Maruyama Tumor immunotherapy agent containing lipopolysaccharide as active principle
WO2013180114A1 (ja) * 2012-05-28 2013-12-05 エヌエーアイ株式会社 認知症の治療剤及び予防剤
WO2022075458A1 (ja) * 2020-10-09 2022-04-14 ゼリア新薬工業株式会社 結核菌抽出物の新規用途
JPWO2022075458A1 (enExample) * 2020-10-09 2022-04-14

Also Published As

Publication number Publication date
CH650799A5 (de) 1985-08-15
ES8105783A1 (es) 1981-06-16
US4329452A (en) 1982-05-11
JPS6256843B2 (enExample) 1987-11-27
IT8023219A0 (it) 1980-07-03
CA1132047A (en) 1982-09-21
US4394502A (en) 1983-07-19
FR2484258A1 (fr) 1981-12-18
ES493061A0 (es) 1981-06-16
SU1232124A3 (ru) 1986-05-15
FR2484258B1 (enExample) 1984-11-30
IT1132168B (it) 1986-06-25

Similar Documents

Publication Publication Date Title
JPS568320A (en) Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent
FR2617848B1 (fr) Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires
CA2086247A1 (en) Food and Pharmaceutical Compositions Containing Short Chain Monounsaturated Fatty Acids and Methods of Using
IL87936A0 (en) Polysulfuric acid esters of bis-aldonamides and their derivatives,the preparation and pharmaceutical compositions containing them
DE3265781D1 (en) New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
AU528098B2 (en) Analgesic tablet
JPS5391189A (en) Preparation of d-n-carbamoyl-alpha-amino acids
GB2020665A (en) Acyl-N-acetylmuramylpeptide- antigen conjugate
ZA871889B (en) Guar flour
JPS5252882A (en) Surfactants
JPS5718619A (en) Tumor immunotherapy agent containing lipopolysaccharide as active principle
JPS5347479A (en) Water-soluble, partially deacetylated chitin and its preparation
JPS5429772A (en) Method of yielding low-cholesterol eggs of domestic fowls
JPS53113093A (en) Preparation of physiological active agent p9-12
JPS52111983A (en) Preparation of heparin derivatives
JPS5278813A (en) Preparation of odorless and stable acetin fat
JPS57130912A (en) High-calorie tranfusion preparation
JPS5321170A (en) Preparation of branched 2-deoxy-alpha-glycosides
JPS5422326A (en) 3-trimethylsilymethyl-3-butenoic acid and its preparation
JPS5270084A (en) Polysaccharide ax
JPS53126090A (en) New fiber and film
JPS5412338A (en) 4-methacryloxyethyl trimellitic acid, its anhydride, and their preparation
JPS642537A (en) Attractant for fishes
JPS51139806A (en) Preparation of wool alcohols and wool fatty acids
JPS55133311A (en) Novel antiallergic agent